You just read:

Trovagene to Present New Data from Onvansertib Phase 2 Study in Metastatic Castration-Resistant Prostate Cancer at Asia-Pacific Prostate Cancer Conference

News provided by

Trovagene, Inc.

Aug 15, 2019, 08:15 ET